Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...
Associations between serum lipids and glaucoma: a cohort study of 400 229 UK Biobank participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback